These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12165034)

  • 1. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
    Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
    Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer.
    Karami N; Talebkhan Y; Saberi S; Esmaeili M; Oghalaie A; Abdirad A; Mostafavi E; Hosseini ME; Mohagheghi MA; Mohammadi M
    Asian Pac J Cancer Prev; 2013; 14(3):1813-7. PubMed ID: 23679279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.
    Palestro G; Pellicano R; Fronda GR; Valente G; De Giuli M; Soldati T; Pugliese A; Taraglio S; Garino M; Campra D; Cutufia MA; Margaria E; Spinzi G; Ferrara A; Marenco G; Rizzetto M; Ponzetto A
    World J Gastroenterol; 2005 Dec; 11(45):7131-5. PubMed ID: 16437659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
    Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
    Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
    Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
    Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T
    FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
    Mitchell HM; Hazell SL; Li YY; Hu PJ
    Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
    Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
    Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
    Yamaoka Y; Kodama T; Kashima K; Graham DY
    J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection in gastric carcinoma.
    Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
    Martín-de-Argila C; Boixeda D; Redondo C; Alvarez I; Gisbert JP; García Plaza A; Cantón R
    Scand J Gastroenterol; 1997 Apr; 32(4):303-7. PubMed ID: 9140150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.